Sutro Biopharma STRO Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$191.09M+16.0% | -$227.46M— | —— | -$119.2M-12.9% | ||
| $7.32M+1.5% | $7.22M+5.9% | $6.82M+19.8% | $5.69M+17.5% | ||
| $14.01M-43.3% | $24.69M-0.9% | $24.91M-5.3% | $26.3M+13.2% | ||
| -$177.23M+11.8% | -$201M— | —— | —— | ||
| —— | —— | —— | —— | ||
| $45.01M-79.4% | $218.51M+5,669% | -$3.92M+88.8% | -$35.02M— | ||
| —— | —— | —— | —— | ||
| $0— | —— | $12.5M— | —— | ||
| —— | $94.08M— | —— | $48.31M+1,366% | ||
| -$134.08M-211% | $121.02M— | —— | —— | ||
| -$177.24M+12.2% | -$201.76M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Sutro Biopharma generate?
- Sutro Biopharma (STRO) generated -$151.6M in operating cash flow over the trailing twelve months.
- What is Sutro Biopharma's free cash flow?
- After $627.0K of capital expenditures, Sutro Biopharma's free cash flow was -$151.6M over the trailing twelve months, up 25.9% year over year.
- Where does Sutro Biopharma's cash flow data come from?
- Every line is extracted from Sutro Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
